Protein arginine methyltransferase 6 enhances ligand-dependent and -independent activity of estrogen receptor α via distinct mechanisms

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 9, 2014, Pages 2067-2078

  Sun, Yang ^a   Chung, Hwa Hwa ^a   Woo, Amanda Rui En ^a   Lin, Valerie C L ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Breast cancer; Chaperone binding; Hsp90; Steroid hormone receptor

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; HEAT SHOCK PROTEIN 90; PROGESTERONE RECEPTOR; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE 6; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MCF 7 CELL LINE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

BREAST CANCER; CHAPERONE BINDING; HSP90; STEROID HORMONE RECEPTOR;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ARGININE; BINDING, COMPETITIVE; BREAST NEOPLASMS; CELL NUCLEUS; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE SILENCING; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LIGANDS; MCF-7 CELLS; METHYLATION; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN-ARGININE N-METHYLTRANSFERASES; RECEPTORS, ANDROGEN; RECEPTORS, GLUCOCORTICOID; RECEPTORS, PROGESTERONE; SRC-FAMILY KINASES; UP-REGULATION;

EID: 84902435601     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.04.008     Document Type: Article

References (56)

1. Couse J.F., Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr. Rev. 1999, 20:358-417.
2. Curtis Hewitt S., Couse J.F., Korach K.S. Estrogen receptor transcription and transactivation: estrogen receptor knockout mice: what their phenotypes reveal about mechanisms of estrogen action. Breast Cancer Res. 2000, 2:345-352.
3. Couse J.F., Korach K.S. Reproductive phenotypes in the estrogen receptor-alpha knockout mouse. Ann. Endocrinol. 1999, 60:143-148.
4. Dupont S., Krust A., Gansmuller A., Dierich A., Chambon P., Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000, 127:4277-4291.
5. Treeck O., Lattrich C., Springwald A., Ortmann O. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells. Breast Cancer Res. Treat. 2009, 120:557-565.
6. Sommer S., Fuqua S.A. Estrogen receptor and breast cancer. Semin. Cancer Biol. 2001, 11:339-352.
7. Frech M.S., Halama E.D., Tilli M.T., Singh B., Gunther E.J., Chodosh L.A., Flaws J.A., Furth P.A. Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ. Cancer Res. 2005, 65:681-685.
8. Aranda A., Pascual A. Nuclear hormone receptors and gene expression. Physiol. Rev. 2001, 81:1269-1304.
9. Metivier R., Penot G., Flouriot G., Pakdel F. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains. Mol. Endocrinol. 2001, 15:1953-1970.
10. Kimmins S., MacRae T.H. Maturation of steroid receptors: an example of functional cooperation among molecular chaperones and their associated proteins. Cell Stress Chaperones 2000, 5:76-86.
11. Pratt W.B., Toft D.O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 1997, 18:306-360.
12. Powell E., Wang Y., Shapiro D.J., Xu W. Differential requirements of Hsp90 and DNA for the formation of estrogen receptor homodimers and heterodimers. J. Biol. Chem. 2010, 285:16125-16134.
13. Bjornstrom L., Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 2005, 19:833-842.
14. Maor S., Mayer D., Yarden R.I., Lee A.V., Sarfstein R., Werner H., Papa M.Z. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. J. Endocrinol. 2006, 191:605-612.
15. Kushner P.J., Agard D.A., Greene G.L., Scanlan T.S., Shiau A.K., Uht R.M., Webb P. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 2000, 74:311-317.
16. Johnston S.R., Dowsett M. Aromatase inhibitors for breast cancer: lessons from the laboratory. Nat. Rev. Cancer 2003, 3:821-831.
17. MacGregor J.I., Jordan V.C. Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev. 1998, 50:151-196.
18. Ali S., Coombes R.C. Endocrine-responsive breast cancer and strategies for combating resistance. Nat. Rev. Cancer 2002, 2:101-112.
19. Musgrove E.A., Sutherland R.L. Biological determinants of endocrine resistance in breast cancer. Nat. Rev. Cancer 2009, 9:631-643.
20. Le Romancer M., Poulard C., Cohen P., Sentis S., Renoir J.M., Corbo L. Cracking the estrogen receptor's posttranslational code in breast tumors. Endocr. Rev. 2011, 32:597-622.
21. Zwijsen R.M., Wientjens E., Klompmaker R., van der Sman J., Bernards R., Michalides R.J. CDK-independent activation of estrogen receptor by cyclin D1. Cell 1997, 88:405-415.
22. Ding L., Yan J., Zhu J., Zhong H., Lu Q., Wang Z., Huang C., Ye Q. Ligand-independent activation of estrogen receptor alpha by XBP-1. Nucleic Acids Res. 2003, 31:5266-5274.
23. Bunone G., Briand P.A., Miksicek R.J., Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 1996, 15:2174-2183.
24. Joel P.B., Smith J., Sturgill T.W., Fisher T.L., Blenis J., Lannigan D.A. pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167. Mol. Cell. Biol. 1998, 18:1978-1984.
25. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995, 270:1491-1494.
26. Coutts A.S., Murphy L.C. Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells. Cancer Res. 1998, 58:4071-4074.
27. Sivaraman V.S., Wang H., Nuovo G.J., Malbon C.C. Hyperexpression of mitogen-activated protein kinase in human breast cancer. J. Clin. Invest. 1997, 99:1478-1483.
28. Gee J.M., Robertson J.F., Ellis I.O., Nicholson R.I. Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer. Int. J. Cancer 2001, 95:247-254.
29. Zwijsen R.M., Buckle R.S., Hijmans E.M., Loomans C.J., Bernards R. Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes Dev. 1998, 12:3488-3498.
30. Xu X.L., Chen S.Z., Chen W., Zheng W.H., Xia X.H., Yang H.J., Li B., Mao W.M. The impact of cyclin D1 overexpression on the prognosis of ER-positive breast cancers: a meta-analysis. Breast Cancer Res. Treat. 2013, 139:329-339.
31. Zhu Y., Singh B., Hewitt S., Liu A., Gomez B., Wang A., Clarke R. Expression patterns among interferon regulatory factor-1, human X-box binding protein-1, nuclear factor kappa B, nucleophosmin, estrogen receptor-alpha and progesterone receptor proteins in breast cancer tissue microarrays. Int. J. Oncol. 2006, 28:67-76.
32. Gomez B.P., Riggins R.B., Shajahan A.N., Klimach U., Wang A., Crawford A.C., Zhu Y., Zwart A., Wang M., Clarke R. Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines. FASEB J. 2007, 21:4013-4027.
33. Koh S.S., Chen D., Lee Y.H., Stallcup M.R. Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J. Biol. Chem. 2001, 276:1089-1098.
34. Qi C., Chang J., Zhu Y., Yeldandi A.V., Rao S.M., Zhu Y.J. Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha. J. Biol. Chem. 2002, 277:28624-28630.
35. Harrison M.J., Tang Y.H., Dowhan D.H. Protein arginine methyltransferase 6 regulates multiple aspects of gene expression. Nucleic Acids Res. 2010, 38:2201-2216.
36. Le Romancer M., Treilleux I., Leconte N., Robin-Lespinasse Y., Sentis S., Bouchekioua-Bouzaghou K., Goddard S., Gobert-Gosse S., Corbo L. Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Mol. Cell 2008, 31:212-221.
37. Phalke S., Mzoughi S., Bezzi M., Jennifer N., Mok W.C., Low D.H., Thike A.A., Kuznetsov V.A., Tan P.H., Voorhoeve P.M., Guccione E. p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6. Nucleic Acids Res. 2012, 40:9534-9542.
38. Neault M., Mallette F.A., Vogel G., Michaud-Levesque J., Richard S. Ablation of PRMT6 reveals a role as a negative transcriptional regulator of the p53 tumor suppressor. Nucleic Acids Res. 2012, 40:9513-9521.
39. Kleinschmidt M.A., de Graaf P., van Teeffelen H.A., Timmers H.T. Cell cycle regulation by the PRMT6 arginine methyltransferase through repression of cyclin-dependent kinase inhibitors. PLoS One 2012, 7:e41446.
40. Stein C., Riedl S., Ruthnick D., Notzold R.R., Bauer U.M. The arginine methyltransferase PRMT6 regulates cell proliferation and senescence through transcriptional repression of tumor suppressor genes. Nucleic Acids Res. 2012, 40:9522-9533.
41. Dowhan D.H., Harrison M.J., Eriksson N.A., Bailey P., Pearen M.A., Fuller P.J., Funder J.W., Simpson E.R., Leedman P.J., Tilley W.D., Brown M.A., Clarke C.L., Muscat G.E. Protein arginine methyltransferase 6-dependent gene expression and splicing: association with breast cancer outcomes. Endocr. Relat. Cancer. 2012, 19:509-526.
42. Sivaramakrishnan G., Sun Y., Tan S.K., Lin V.C. Dynamic localization of tripartite motif-containing 22 in nuclear and nucleolar bodies. Exp. Cell Res. 2009, 315:1521-1532.
43. Frankel A., Yadav N., Lee J., Branscombe T.L., Clarke S., Bedford M.T. The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity. J. Biol. Chem. 2002, 277:3537-3543.
44. Hu Q., Kwon Y.S., Nunez E., Cardamone M.D., Hutt K.R., Ohgi K.A., Garcia-Bassets I., Rose D.W., Glass C.K., Rosenfeld M.G., Fu X.D. Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19199-19204.
45. Cook P.R. The organization of replication and transcription. Science 1999, 284:1790-1795.
46. Zhang Y., Wong C.H., Birnbaum R.Y., Li G., Favaro R., Ngan C.Y., Lim J., Tai E., Poh H.M., Wong E., Mulawadi F.H., Sung W.K., Nicolis S., Ahituv N., Ruan Y., Wei C.L. Chromatin connectivity maps reveal dynamic promoter-enhancer long-range associations. Nature 2013, 504:306-310.
47. Picard D. The role of heat shock proteins in the regulation of steroid receptor function. The Molecular Biology of Steroid and Nuclear Hormone Receptors 1998, 1-18. B. Birkhaüser, L.P. Freedman (Eds.).
48. Chambraud B., Berry M., Redeuilh G., Chambon P., Baulieu E.E. Several regions of human estrogen receptor are involved in the formation of receptor-heat shock protein 90 complexes. J. Biol. Chem. 1990, 265:20686-20691.
49. Yoshimatsu M., Toyokawa G., Hayami S., Unoki M., Tsunoda T., Field H.I., Kelly J.D., Neal D.E., Maehara Y., Ponder B.A., Nakamura Y., Hamamoto R. Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers. Int. J. Cancer 2010, 128:562-573.
50. Hache R.J., Tse R., Reich T., Savory J.G., Lefebvre Y.A. Nucleocytoplasmic trafficking of steroid-free glucocorticoid receptor. J. Biol. Chem. 1999, 274:1432-1439.
51. Hyllus D., Stein C., Schnabel K., Schiltz E., Imhof A., Dou Y., Hsieh J., Bauer U.M. PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation. Genes Dev. 2007, 21:3369-3380.
52. Wang X., Huang Y., Zhao J., Zhang Y., Lu J., Huang B. Suppression of PRMT6-mediated arginine methylation of p16 protein potentiates its ability to arrest A549 cell proliferation. Int. J. Biochem. Cell Biol. 2012, 44:2333-2341.
53. Shou J., Massarweh S., Osborne C.K., Wakeling A.E., Ali S., Weiss H., Schiff R. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. J. Natl. Cancer Inst. 2004, 96:926-935.
54. Gutierrez M.C., Detre S., Johnston S., Mohsin S.K., Shou J., Allred D.C., Schiff R., Osborne C.K., Dowsett M. Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase. J. Clin. Oncol. 2005, 23:2469-2476.
55. Chen D., Ma H., Hong H., Koh S.S., Huang S.M., Schurter B.T., Aswad D.W., Stallcup M.R. Regulation of transcription by a protein methyltransferase. Science 1999, 284:2174-2177.
56. Osborne C.K., Schiff R. Mechanisms of endocrine resistance in breast cancer. Annu. Rev. Med. 2011, 62:233-247.